Table 2 Simulation results: estimated burden under vaccination and no-vaccination scenarios using disease model X 2. Results indicate the total burden for individuals acutely infected in simulation year 1, with 95% quantile intervals
Model variant [–Vacc. scenario] | Acute cases | YLD | YLL (95% interval) | DALY (95% interval) | Burden averted DALY (%) |
|---|---|---|---|---|---|
X 2 No heterogeneity | |||||
– No vaccination | 5000 | 10750 | 10210 (9380–11090) | 20960 (20140–21740) | – |
– Vaccination <20 year | 2768 | 5212 | 4066 (3537–4635) | 9280 (8765–9770) | 11680 (55.7%) |
X 2 Heterogeneity a | |||||
– No vaccination | 5000 | 11010 | 9074 (8411–9887) | 20090 (19440–20780) | – |
– Vaccination <20 year | 2768 | 5252 | 3693 (3259–4145) | 8945 (8536–9374) | 11140 (55.0%) |